The global Contrast-Enhanced Mammography market was valued at US$ 301 million in 2025 and is anticipated to reach US$ 455 million by 2032, at a CAGR of 6.1% from 2026 to 2032.

Contrast-Enhanced Mammography Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Contrast-Enhanced Mammography competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Contrast-Enhanced Mammography (CEM) is a breast imaging technique that builds on standard digital mammography by administering intravenous iodinated contrast and acquiring dual-energy images (low- and high-energy) to reconstruct enhancement/“iodine-only” images. It provides both anatomic detail (similar to conventional mammography) and functional information related to vascularity and permeability, making contrast uptake more conspicuous in many cancers. CEM is particularly relevant for dense breasts, problem-solving in equivocal cases, scenarios where breast MRI is contraindicated or less accessible, and selected pathways such as preoperative evaluation and treatment follow-up. Its clinical and operational value depends on standardized contrast administration and timing, a robust dual-energy imaging chain, and workflow-integrated reading and reporting—so performance gains translate into reproducible, scalable practice. In 2025, global Contrast-Enhanced Mammography production reached approximately 1506 unit and price is about 200 K USD/Unit.The average gross profit margin of this product is 50%.

Sustained demand for earlier detection and higher-throughput breast imaging is pushing radiology departments to adopt solutions that improve sensitivity without disrupting established mammography infrastructure. CEM supports “bringing enhancement capability onto the mammography platform,” leveraging familiar equipment ecosystems and scalable protocols. For providers, CEM can serve as a complementary—or in selected indications, alternative—pathway to breast MRI, helping shorten diagnostic timelines, improve access, and align enhancement imaging with existing mammography workflows, QC frameworks, and staffing models. CEM combines contrast administration, radiation-based imaging, and workflow governance, meaning implementation barriers extend beyond hardware to patient screening (e.g., contrast reactions and renal considerations), timing control, emergency readiness, and cross-team coordination. Clinically, positioning CEM alongside MRI, ultrasound, and tomosynthesis requires clear boundaries and standardized interpretation training to avoid excessive false positives or unnecessary follow-ups. Without strong evidence loops and disciplined QC, hospitals may face uncertainty in defining CEM’s role and sustaining consistent utilization. Demand is shifting from single-test accuracy to pathway-level efficiency—linking CEM with tomosynthesis, targeted ultrasound, biopsy workflows, and preoperative decision-making to enable faster, more streamlined “test-to-decision” cycles. In practice, CEM is often expected to deliver the greatest incremental value in dense breasts, lesion stratification, and MRI-limited populations, with gradual expansion into higher-frequency follow-up and recurrence surveillance scenarios. Meanwhile, radiology leaders increasingly prioritize structured reporting, AI assistance, and cross-site consistency to operationalize quality at scale. The upstream value chain is anchored by “contrast agent & injection systems + dual-energy mammography platform + software/QA components.” Iodinated contrast media and injectors/consumables define administration stability and safety boundaries; dual-energy detectors, x-ray tubes, generators, and compression mechanics drive image consistency and reproducibility; and reconstruction/post-processing software (low-energy images, iodine/enhancement images, artifact suppression, dose management) determines readability and workflow efficiency. Competitive differentiation concentrates on balancing low dose with high contrast, user-friendly reconstruction and reading software, integration with RIS/PACS and structured reporting, and lifecycle QA and service delivery capabilities.

This report delivers a comprehensive overview of the global Contrast-Enhanced Mammography market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Contrast-Enhanced Mammography. The Contrast-Enhanced Mammography market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Contrast-Enhanced Mammography market comprehensively. Regional market sizes by Type, by Application, by Clinical Purpose, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Contrast-Enhanced Mammography manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Contrast-Enhanced Mammography Market Report

Report Metric	Details
Report Name	Contrast-Enhanced Mammography Market
Accounted market size in 2025	US$ 301 million
Forecasted market size in 2032	US$ 455 million
CAGR	6.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Dual-energy CEM Single-energy Enhanced
Segment by Clinical Purpose	Screening Diagnostic Workup Pre-op Staging Other
Segment by Equipment Type	Dedicated CEM Mammography Upgrade from Standard System Other
by Application	Hospital Physical Examination Center Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Hologic, GE Healthcare, Siemens, FUJIFILM, Philips Healthcare, Canon Medical, IMS Giotto, Planmed, Carestream Health, Metaltronica, MEDI-FUTURE, Wandong Medical, ANKE, Sino MDT, Angell, United Imaging Healthcare, Alltech Healthcare, Neusoft Healthcare, SevenHealth
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Clinical Purpose, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Contrast-Enhanced Mammography manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Contrast-Enhanced Mammography sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Contrast-Enhanced Mammography Market growing?

Ans: The Contrast-Enhanced Mammography Market witnessing a CAGR of 6.1% during the forecast period 2026-2032.

What is the Contrast-Enhanced Mammography Market size in 2032?

Ans: The Contrast-Enhanced Mammography Market size in 2032 will be US$ 455 million.

Who are the main players in the Contrast-Enhanced Mammography Market report?

Ans: The main players in the Contrast-Enhanced Mammography Market are Hologic, GE Healthcare, Siemens, FUJIFILM, Philips Healthcare, Canon Medical, IMS Giotto, Planmed, Carestream Health, Metaltronica, MEDI-FUTURE, Wandong Medical, ANKE, Sino MDT, Angell, United Imaging Healthcare, Alltech Healthcare, Neusoft Healthcare, SevenHealth

What are the Application segmentation covered in the Contrast-Enhanced Mammography Market report?

Ans: The Applications covered in the Contrast-Enhanced Mammography Market report are Hospital, Physical Examination Center, Other

What are the Type segmentation covered in the Contrast-Enhanced Mammography Market report?

Ans: The Types covered in the Contrast-Enhanced Mammography Market report are Dedicated CEM Mammography, Upgrade from Standard System, Other

1 Contrast-Enhanced Mammography Market Overview

1.1 Product Definition

1.2 Contrast-Enhanced Mammography by Type

1.2.1 Global Contrast-Enhanced Mammography Market Value by Type: 2025 vs 2032

1.2.2 Dual-energy CEM

1.2.3 Single-energy Enhanced

1.3 Contrast-Enhanced Mammography by Clinical Purpose

1.3.1 Global Contrast-Enhanced Mammography Market Value by Clinical Purpose: 2025 vs 2032

1.3.2 Screening

1.3.3 Diagnostic Workup

1.3.4 Pre-op Staging

1.3.5 Other

1.4 Contrast-Enhanced Mammography by Equipment Type

1.4.1 Global Contrast-Enhanced Mammography Market Value by Equipment Type: 2025 vs 2032

1.4.2 Dedicated CEM Mammography

1.4.3 Upgrade from Standard System

1.4.4 Other

1.5 Contrast-Enhanced Mammography by Application

1.5.1 Global Contrast-Enhanced Mammography Market Value by Application: 2025 vs 2032

1.5.2 Hospital

1.5.3 Physical Examination Center

1.5.4 Other

1.6 Global Contrast-Enhanced Mammography Market Size Estimates and Forecasts

1.6.1 Global Contrast-Enhanced Mammography Revenue 2021–2032

1.6.2 Global Contrast-Enhanced Mammography Sales 2021–2032

1.6.3 Global Contrast-Enhanced Mammography Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Contrast-Enhanced Mammography Market Competition by Manufacturers

2.1 Global Contrast-Enhanced Mammography Sales Market Share by Manufacturers (2021–2026)

2.2 Global Contrast-Enhanced Mammography Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Contrast-Enhanced Mammography Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Contrast-Enhanced Mammography, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Contrast-Enhanced Mammography, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Contrast-Enhanced Mammography, Product Types and Applications

2.7 Global Key Manufacturers of Contrast-Enhanced Mammography, Date of Entry into the Industry

2.8 Global Contrast-Enhanced Mammography Market Competitive Situation and Trends

2.8.1 Global Contrast-Enhanced Mammography Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Contrast-Enhanced Mammography Players Market Share by Revenue

2.8.3 Global Contrast-Enhanced Mammography Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Contrast-Enhanced Mammography Market Scenario by Region

3.1 Global Contrast-Enhanced Mammography Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Contrast-Enhanced Mammography Sales by Region: 2021–2032

3.2.1 Global Contrast-Enhanced Mammography Sales by Region: 2021–2026

3.2.2 Global Contrast-Enhanced Mammography Sales by Region: 2027–2032

3.3 Global Contrast-Enhanced Mammography Revenue by Region: 2021–2032

3.3.1 Global Contrast-Enhanced Mammography Revenue by Region: 2021–2026

3.3.2 Global Contrast-Enhanced Mammography Revenue by Region: 2027–2032

3.4 North America Contrast-Enhanced Mammography Market Facts & Figures by Country

3.4.1 North America Contrast-Enhanced Mammography Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Contrast-Enhanced Mammography Sales by Country (2021–2032)

3.4.3 North America Contrast-Enhanced Mammography Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Contrast-Enhanced Mammography Market Facts & Figures by Country

3.5.1 Europe Contrast-Enhanced Mammography Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Contrast-Enhanced Mammography Sales by Country (2021–2032)

3.5.3 Europe Contrast-Enhanced Mammography Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Contrast-Enhanced Mammography Market Facts & Figures by Region

3.6.1 Asia Pacific Contrast-Enhanced Mammography Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Contrast-Enhanced Mammography Sales by Region (2021–2032)

3.6.3 Asia Pacific Contrast-Enhanced Mammography Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Contrast-Enhanced Mammography Market Facts & Figures by Country

3.7.1 Latin America Contrast-Enhanced Mammography Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Contrast-Enhanced Mammography Sales by Country (2021–2032)

3.7.3 Latin America Contrast-Enhanced Mammography Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Contrast-Enhanced Mammography Market Facts & Figures by Country

3.8.1 Middle East and Africa Contrast-Enhanced Mammography Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Contrast-Enhanced Mammography Sales by Country (2021–2032)

3.8.3 Middle East and Africa Contrast-Enhanced Mammography Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Contrast-Enhanced Mammography Sales by Type (2021–2032)

4.1.1 Global Contrast-Enhanced Mammography Sales by Type (2021–2026)

4.1.2 Global Contrast-Enhanced Mammography Sales by Type (2027–2032)

4.1.3 Global Contrast-Enhanced Mammography Sales Market Share by Type (2021–2032)

4.2 Global Contrast-Enhanced Mammography Revenue by Type (2021–2032)

4.2.1 Global Contrast-Enhanced Mammography Revenue by Type (2021–2026)

4.2.2 Global Contrast-Enhanced Mammography Revenue by Type (2027–2032)

4.2.3 Global Contrast-Enhanced Mammography Revenue Market Share by Type (2021–2032)

4.3 Global Contrast-Enhanced Mammography Price by Type (2021–2032)

5 Segment by Application

5.1 Global Contrast-Enhanced Mammography Sales by Application (2021–2032)

5.1.1 Global Contrast-Enhanced Mammography Sales by Application (2021–2026)

5.1.2 Global Contrast-Enhanced Mammography Sales by Application (2027–2032)

5.1.3 Global Contrast-Enhanced Mammography Sales Market Share by Application (2021–2032)

5.2 Global Contrast-Enhanced Mammography Revenue by Application (2021–2032)

5.2.1 Global Contrast-Enhanced Mammography Revenue by Application (2021–2026)

5.2.2 Global Contrast-Enhanced Mammography Revenue by Application (2027–2032)

5.2.3 Global Contrast-Enhanced Mammography Revenue Market Share by Application (2021–2032)

5.3 Global Contrast-Enhanced Mammography Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Hologic

6.1.1 Hologic Company Information

6.1.2 Hologic Description and Business Overview

6.1.3 Hologic Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Hologic Contrast-Enhanced Mammography Product Portfolio

6.1.5 Hologic Recent Developments/Updates

6.2 GE Healthcare

6.2.1 GE Healthcare Company Information

6.2.2 GE Healthcare Description and Business Overview

6.2.3 GE Healthcare Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 GE Healthcare Contrast-Enhanced Mammography Product Portfolio

6.2.5 GE Healthcare Recent Developments/Updates

6.3 Siemens

6.3.1 Siemens Company Information

6.3.2 Siemens Description and Business Overview

6.3.3 Siemens Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Siemens Contrast-Enhanced Mammography Product Portfolio

6.3.5 Siemens Recent Developments/Updates

6.4 FUJIFILM

6.4.1 FUJIFILM Company Information

6.4.2 FUJIFILM Description and Business Overview

6.4.3 FUJIFILM Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 FUJIFILM Contrast-Enhanced Mammography Product Portfolio

6.4.5 FUJIFILM Recent Developments/Updates

6.5 Philips Healthcare

6.5.1 Philips Healthcare Company Information

6.5.2 Philips Healthcare Description and Business Overview

6.5.3 Philips Healthcare Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Philips Healthcare Contrast-Enhanced Mammography Product Portfolio

6.5.5 Philips Healthcare Recent Developments/Updates

6.6 Canon Medical

6.6.1 Canon Medical Company Information

6.6.2 Canon Medical Description and Business Overview

6.6.3 Canon Medical Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Canon Medical Contrast-Enhanced Mammography Product Portfolio

6.6.5 Canon Medical Recent Developments/Updates

6.7 IMS Giotto

6.7.1 IMS Giotto Company Information

6.7.2 IMS Giotto Description and Business Overview

6.7.3 IMS Giotto Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 IMS Giotto Contrast-Enhanced Mammography Product Portfolio

6.7.5 IMS Giotto Recent Developments/Updates

6.8 Planmed

6.8.1 Planmed Company Information

6.8.2 Planmed Description and Business Overview

6.8.3 Planmed Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Planmed Contrast-Enhanced Mammography Product Portfolio

6.8.5 Planmed Recent Developments/Updates

6.9 Carestream Health

6.9.1 Carestream Health Company Information

6.9.2 Carestream Health Description and Business Overview

6.9.3 Carestream Health Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Carestream Health Contrast-Enhanced Mammography Product Portfolio

6.9.5 Carestream Health Recent Developments/Updates

6.10 Metaltronica

6.10.1 Metaltronica Company Information

6.10.2 Metaltronica Description and Business Overview

6.10.3 Metaltronica Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Metaltronica Contrast-Enhanced Mammography Product Portfolio

6.10.5 Metaltronica Recent Developments/Updates

6.11 MEDI-FUTURE

6.11.1 MEDI-FUTURE Company Information

6.11.2 MEDI-FUTURE Description and Business Overview

6.11.3 MEDI-FUTURE Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 MEDI-FUTURE Contrast-Enhanced Mammography Product Portfolio

6.11.5 MEDI-FUTURE Recent Developments/Updates

6.12 Wandong Medical

6.12.1 Wandong Medical Company Information

6.12.2 Wandong Medical Description and Business Overview

6.12.3 Wandong Medical Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Wandong Medical Contrast-Enhanced Mammography Product Portfolio

6.12.5 Wandong Medical Recent Developments/Updates

6.13 ANKE

6.13.1 ANKE Company Information

6.13.2 ANKE Description and Business Overview

6.13.3 ANKE Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 ANKE Contrast-Enhanced Mammography Product Portfolio

6.13.5 ANKE Recent Developments/Updates

6.14 Sino MDT

6.14.1 Sino MDT Company Information

6.14.2 Sino MDT Description and Business Overview

6.14.3 Sino MDT Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Sino MDT Contrast-Enhanced Mammography Product Portfolio

6.14.5 Sino MDT Recent Developments/Updates

6.15 Angell

6.15.1 Angell Company Information

6.15.2 Angell Description and Business Overview

6.15.3 Angell Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Angell Contrast-Enhanced Mammography Product Portfolio

6.15.5 Angell Recent Developments/Updates

6.16 United Imaging Healthcare

6.16.1 United Imaging Healthcare Company Information

6.16.2 United Imaging Healthcare Description and Business Overview

6.16.3 United Imaging Healthcare Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 United Imaging Healthcare Contrast-Enhanced Mammography Product Portfolio

6.16.5 United Imaging Healthcare Recent Developments/Updates

6.17 Alltech Healthcare

6.17.1 Alltech Healthcare Company Information

6.17.2 Alltech Healthcare Description and Business Overview

6.17.3 Alltech Healthcare Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 Alltech Healthcare Contrast-Enhanced Mammography Product Portfolio

6.17.5 Alltech Healthcare Recent Developments/Updates

6.18 Neusoft Healthcare

6.18.1 Neusoft Healthcare Company Information

6.18.2 Neusoft Healthcare Description and Business Overview

6.18.3 Neusoft Healthcare Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.18.4 Neusoft Healthcare Contrast-Enhanced Mammography Product Portfolio

6.18.5 Neusoft Healthcare Recent Developments/Updates

6.19 SevenHealth

6.19.1 SevenHealth Company Information

6.19.2 SevenHealth Description and Business Overview

6.19.3 SevenHealth Contrast-Enhanced Mammography Sales, Revenue, and Gross Margin (2021–2026)

6.19.4 SevenHealth Contrast-Enhanced Mammography Product Portfolio

6.19.5 SevenHealth Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Contrast-Enhanced Mammography Industry Chain Analysis

7.2 Contrast-Enhanced Mammography Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Contrast-Enhanced Mammography Production Mode & Process Analysis

7.4 Contrast-Enhanced Mammography Sales and Marketing

7.4.1 Contrast-Enhanced Mammography Sales Channels

7.4.2 Contrast-Enhanced Mammography Distributors

7.5 Contrast-Enhanced Mammography Customer Analysis

8 Contrast-Enhanced Mammography Market Dynamics

8.1 Contrast-Enhanced Mammography Industry Trends

8.2 Contrast-Enhanced Mammography Market Drivers

8.3 Contrast-Enhanced Mammography Market Challenges

8.4 Contrast-Enhanced Mammography Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

United Imaging Healthcare

Alltech Healthcare

Neusoft Healthcare

SevenHealth

List of Tables

Table 1. Global Contrast-Enhanced Mammography Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Contrast-Enhanced Mammography Market Value by Clinical Purpose (US$ Million), 2025 vs 2032

Table 3. Global Contrast-Enhanced Mammography Market Value by Equipment Type (US$ Million), 2025 vs 2032

Table 4. Global Contrast-Enhanced Mammography Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Contrast-Enhanced Mammography Market Competitive Situation by Manufacturers in 2025

Table 6. Global Contrast-Enhanced Mammography Sales (Units) of Key Manufacturers (2021–2026)

Table 7. Global Contrast-Enhanced Mammography Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Contrast-Enhanced Mammography Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Contrast-Enhanced Mammography Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Contrast-Enhanced Mammography Average Price (K USD/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Contrast-Enhanced Mammography, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Contrast-Enhanced Mammography, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Contrast-Enhanced Mammography, Product Types and Applications

Table 14. Global Key Manufacturers of Contrast-Enhanced Mammography, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Contrast-Enhanced Mammography Companies by Tier (Tier 1, Tier 2, Tier 3), based on Contrast-Enhanced Mammography Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Contrast-Enhanced Mammography Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Contrast-Enhanced Mammography Sales by Region (Units), 2021–2026

Table 20. Global Contrast-Enhanced Mammography Sales Market Share by Region (2021–2026)

Table 21. Global Contrast-Enhanced Mammography Sales by Region (Units), 2027–2032

Table 22. Global Contrast-Enhanced Mammography Sales Market Share by Region (2027–2032)

Table 23. Global Contrast-Enhanced Mammography Revenue by Region (US$ Million), 2021–2026

Table 24. Global Contrast-Enhanced Mammography Revenue Market Share by Region (2021–2026)

Table 25. Global Contrast-Enhanced Mammography Revenue by Region (US$ Million), 2027–2032

Table 26. Global Contrast-Enhanced Mammography Revenue Market Share by Region (2027–2032)

Table 27. North America Contrast-Enhanced Mammography Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Contrast-Enhanced Mammography Sales by Country (Units), 2021–2026

Table 29. North America Contrast-Enhanced Mammography Sales by Country (Units), 2027–2032

Table 30. North America Contrast-Enhanced Mammography Revenue by Country (US$ Million), 2021–2026

Table 31. North America Contrast-Enhanced Mammography Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Contrast-Enhanced Mammography Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Contrast-Enhanced Mammography Sales by Country (Units), 2021–2026

Table 34. Europe Contrast-Enhanced Mammography Sales by Country (Units), 2027–2032

Table 35. Europe Contrast-Enhanced Mammography Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Contrast-Enhanced Mammography Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Contrast-Enhanced Mammography Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Contrast-Enhanced Mammography Sales by Region (Units), 2021–2026

Table 39. Asia Pacific Contrast-Enhanced Mammography Sales by Region (Units), 2027–2032

Table 40. Asia Pacific Contrast-Enhanced Mammography Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Contrast-Enhanced Mammography Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Contrast-Enhanced Mammography Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Contrast-Enhanced Mammography Sales by Country (Units), 2021–2026

Table 44. Latin America Contrast-Enhanced Mammography Sales by Country (Units), 2027–2032

Table 45. Latin America Contrast-Enhanced Mammography Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Contrast-Enhanced Mammography Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Contrast-Enhanced Mammography Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Contrast-Enhanced Mammography Sales by Country (Units), 2021–2026

Table 49. Middle East and Africa Contrast-Enhanced Mammography Sales by Country (Units), 2027–2032

Table 50. Middle East and Africa Contrast-Enhanced Mammography Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Contrast-Enhanced Mammography Revenue by Country (US$ Million), 2027–2032

Table 52. Global Contrast-Enhanced Mammography Sales (Units) by Type (2021–2026)

Table 53. Global Contrast-Enhanced Mammography Sales (Units) by Type (2027–2032)

Table 54. Global Contrast-Enhanced Mammography Sales Market Share by Type (2021–2026)

Table 55. Global Contrast-Enhanced Mammography Sales Market Share by Type (2027–2032)

Table 56. Global Contrast-Enhanced Mammography Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Contrast-Enhanced Mammography Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Contrast-Enhanced Mammography Revenue Market Share by Type (2021–2026)

Table 59. Global Contrast-Enhanced Mammography Revenue Market Share by Type (2027–2032)

Table 60. Global Contrast-Enhanced Mammography Price (K USD/Unit) by Type (2021–2026)

Table 61. Global Contrast-Enhanced Mammography Price (K USD/Unit) by Type (2027–2032)

Table 62. Global Contrast-Enhanced Mammography Sales (Units) by Application (2021–2026)

Table 63. Global Contrast-Enhanced Mammography Sales (Units) by Application (2027–2032)

Table 64. Global Contrast-Enhanced Mammography Sales Market Share by Application (2021–2026)

Table 65. Global Contrast-Enhanced Mammography Sales Market Share by Application (2027–2032)

Table 66. Global Contrast-Enhanced Mammography Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Contrast-Enhanced Mammography Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Contrast-Enhanced Mammography Revenue Market Share by Application (2021–2026)

Table 69. Global Contrast-Enhanced Mammography Revenue Market Share by Application (2027–2032)

Table 70. Global Contrast-Enhanced Mammography Price (K USD/Unit) by Application (2021–2026)

Table 71. Global Contrast-Enhanced Mammography Price (K USD/Unit) by Application (2027–2032)

Table 72. Hologic Company Information

Table 73. Hologic Description and Business Overview

Table 74. Hologic Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 75. Hologic Contrast-Enhanced Mammography Product

Table 76. Hologic Recent Developments/Updates

Table 77. GE Healthcare Company Information

Table 78. GE Healthcare Description and Business Overview

Table 79. GE Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 80. GE Healthcare Contrast-Enhanced Mammography Product

Table 81. GE Healthcare Recent Developments/Updates

Table 82. Siemens Company Information

Table 83. Siemens Description and Business Overview

Table 84. Siemens Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 85. Siemens Contrast-Enhanced Mammography Product

Table 86. Siemens Recent Developments/Updates

Table 87. FUJIFILM Company Information

Table 88. FUJIFILM Description and Business Overview

Table 89. FUJIFILM Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 90. FUJIFILM Contrast-Enhanced Mammography Product

Table 91. FUJIFILM Recent Developments/Updates

Table 92. Philips Healthcare Company Information

Table 93. Philips Healthcare Description and Business Overview

Table 94. Philips Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 95. Philips Healthcare Contrast-Enhanced Mammography Product

Table 96. Philips Healthcare Recent Developments/Updates

Table 97. Canon Medical Company Information

Table 98. Canon Medical Description and Business Overview

Table 99. Canon Medical Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 100. Canon Medical Contrast-Enhanced Mammography Product

Table 101. Canon Medical Recent Developments/Updates

Table 102. IMS Giotto Company Information

Table 103. IMS Giotto Description and Business Overview

Table 104. IMS Giotto Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 105. IMS Giotto Contrast-Enhanced Mammography Product

Table 106. IMS Giotto Recent Developments/Updates

Table 107. Planmed Company Information

Table 108. Planmed Description and Business Overview

Table 109. Planmed Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 110. Planmed Contrast-Enhanced Mammography Product

Table 111. Planmed Recent Developments/Updates

Table 112. Carestream Health Company Information

Table 113. Carestream Health Description and Business Overview

Table 114. Carestream Health Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 115. Carestream Health Contrast-Enhanced Mammography Product

Table 116. Carestream Health Recent Developments/Updates

Table 117. Metaltronica Company Information

Table 118. Metaltronica Description and Business Overview

Table 119. Metaltronica Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 120. Metaltronica Contrast-Enhanced Mammography Product

Table 121. Metaltronica Recent Developments/Updates

Table 122. MEDI-FUTURE Company Information

Table 123. MEDI-FUTURE Description and Business Overview

Table 124. MEDI-FUTURE Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 125. MEDI-FUTURE Contrast-Enhanced Mammography Product

Table 126. MEDI-FUTURE Recent Developments/Updates

Table 127. Wandong Medical Company Information

Table 128. Wandong Medical Description and Business Overview

Table 129. Wandong Medical Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 130. Wandong Medical Contrast-Enhanced Mammography Product

Table 131. Wandong Medical Recent Developments/Updates

Table 132. ANKE Company Information

Table 133. ANKE Description and Business Overview

Table 134. ANKE Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 135. ANKE Contrast-Enhanced Mammography Product

Table 136. ANKE Recent Developments/Updates

Table 137. Sino MDT Company Information

Table 138. Sino MDT Description and Business Overview

Table 139. Sino MDT Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 140. Sino MDT Contrast-Enhanced Mammography Product

Table 141. Sino MDT Recent Developments/Updates

Table 142. Angell Company Information

Table 143. Angell Description and Business Overview

Table 144. Angell Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 145. Angell Contrast-Enhanced Mammography Product

Table 146. Angell Recent Developments/Updates

Table 147. United Imaging Healthcare Company Information

Table 148. United Imaging Healthcare Description and Business Overview

Table 149. United Imaging Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 150. United Imaging Healthcare Contrast-Enhanced Mammography Product

Table 151. United Imaging Healthcare Recent Developments/Updates

Table 152. Alltech Healthcare Company Information

Table 153. Alltech Healthcare Description and Business Overview

Table 154. Alltech Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 155. Alltech Healthcare Contrast-Enhanced Mammography Product

Table 156. Alltech Healthcare Recent Developments/Updates

Table 157. Neusoft Healthcare Company Information

Table 158. Neusoft Healthcare Description and Business Overview

Table 159. Neusoft Healthcare Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 160. Neusoft Healthcare Contrast-Enhanced Mammography Product

Table 161. Neusoft Healthcare Recent Developments/Updates

Table 162. SevenHealth Company Information

Table 163. SevenHealth Description and Business Overview

Table 164. SevenHealth Contrast-Enhanced Mammography Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)

Table 165. SevenHealth Contrast-Enhanced Mammography Product

Table 166. SevenHealth Recent Developments/Updates

Table 167. Key Raw Materials Lists

Table 168. Raw Materials Key Suppliers Lists

Table 169. Contrast-Enhanced Mammography Distributors List

Table 170. Contrast-Enhanced Mammography Customers List

Table 171. Contrast-Enhanced Mammography Market Trends

Table 172. Contrast-Enhanced Mammography Market Drivers

Table 173. Contrast-Enhanced Mammography Market Challenges

Table 174. Contrast-Enhanced Mammography Market Restraints

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

Table 178. Authors List of This Report

List of Figures

Figure 1. Product Picture of Contrast-Enhanced Mammography

Figure 2. Global Contrast-Enhanced Mammography Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Contrast-Enhanced Mammography Market Share by Type: 2025 & 2032

Figure 4. Dual-energy CEM Product Picture

Figure 5. Single-energy Enhanced Product Picture

Figure 6. Global Contrast-Enhanced Mammography Market Value by Clinical Purpose (US$ Million), 2021–2032

Figure 7. Global Contrast-Enhanced Mammography Market Share by Clinical Purpose: 2025 vs 2032

Figure 8. Screening Product Picture

Figure 9. Diagnostic Workup Product Picture

Figure 10. Pre-op Staging Product Picture

Figure 11. Other Product Picture

Figure 12. Global Contrast-Enhanced Mammography Market Value by Equipment Type (US$ Million), 2021–2032

Figure 13. Global Contrast-Enhanced Mammography Market Share by Equipment Type: 2025 vs 2032

Figure 14. Dedicated CEM Mammography Product Picture

Figure 15. Upgrade from Standard System Product Picture

Figure 16. Other Product Picture

Figure 17. Global Contrast-Enhanced Mammography Market Value by Application (US$ Million), 2021–2032

Figure 18. Global Contrast-Enhanced Mammography Market Share by Application: 2025 & 2032

Figure 19. Hospital

Figure 20. Physical Examination Center

Figure 21. Other

Figure 22. Global Contrast-Enhanced Mammography Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Contrast-Enhanced Mammography Market Size (US$ Million), 2021–2032

Figure 24. Global Contrast-Enhanced Mammography Sales (Units), 2021–2032

Figure 25. Global Contrast-Enhanced Mammography Average Price (K USD/Unit), 2021–2032

Figure 26. Contrast-Enhanced Mammography Report Years Considered

Figure 27. Contrast-Enhanced Mammography Sales Share by Manufacturers in 2025

Figure 28. Global Contrast-Enhanced Mammography Revenue Share by Manufacturers in 2025

Figure 29. Top 5 and Top 10 Global Contrast-Enhanced Mammography Players: Market Share by Revenue in Contrast-Enhanced Mammography in 2025

Figure 30. Contrast-Enhanced Mammography Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 31. Global Contrast-Enhanced Mammography Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 32. North America Contrast-Enhanced Mammography Sales Market Share by Country (2021–2032)

Figure 33. North America Contrast-Enhanced Mammography Revenue Market Share by Country (2021–2032)

Figure 34. U.S. Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Canada Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Europe Contrast-Enhanced Mammography Sales Market Share by Country (2021–2032)

Figure 37. Europe Contrast-Enhanced Mammography Revenue Market Share by Country (2021–2032)

Figure 38. Germany Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. France Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. U.K. Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Italy Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Russia Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Asia Pacific Contrast-Enhanced Mammography Sales Market Share by Region (2021–2032)

Figure 44. Asia Pacific Contrast-Enhanced Mammography Revenue Market Share by Region (2021–2032)

Figure 45. China Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Japan Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. South Korea Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. India Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Australia Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. China Taiwan Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Indonesia Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Thailand Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Malaysia Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Latin America Contrast-Enhanced Mammography Sales Market Share by Country (2021–2032)

Figure 55. Latin America Contrast-Enhanced Mammography Revenue Market Share by Country (2021–2032)

Figure 56. Mexico Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Brazil Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Argentina Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Middle East and Africa Contrast-Enhanced Mammography Sales Market Share by Country (2021–2032)

Figure 60. Middle East and Africa Contrast-Enhanced Mammography Revenue Market Share by Country (2021–2032)

Figure 61. Turkey Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Saudi Arabia Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. UAE Contrast-Enhanced Mammography Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. Global Sales Market Share of Contrast-Enhanced Mammography by Type (2021–2032)

Figure 65. Global Revenue Market Share of Contrast-Enhanced Mammography by Type (2021–2032)

Figure 66. Global Contrast-Enhanced Mammography Price (K USD/Unit) by Type (2021–2032)

Figure 67. Global Sales Market Share of Contrast-Enhanced Mammography by Application (2021–2032)

Figure 68. Global Revenue Market Share of Contrast-Enhanced Mammography by Application (2021–2032)

Figure 69. Global Contrast-Enhanced Mammography Price (K USD/Unit) by Application (2021–2032)

Figure 70. Contrast-Enhanced Mammography Value Chain

Figure 71. Channels of Distribution (Direct Vs Distribution)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions